Why and how protein aggregation has to be studied in vivo

Microbial Cell Factories

Volumn 12, Issue 1, 2013, Pages

  Ami, Diletta ^a   Natalello, Antonino ^a   Lotti, Marina ^a   Doglia, Silvia Maria ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Amyloids; Inclusion bodies; Intact cells; Protein aggregation; Spectroscopy

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ALPHA HELIX; BACTERIAL CELL; BIOCHEMISTRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; IN VIVO CULTURE; INFRARED SPECTROSCOPY; NONHUMAN; NOTE; NUCLEAR MAGNETIC RESONANCE; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING;

AMYLOID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR CHAPERONES; NEURODEGENERATIVE DISEASES; PEPTIDE HYDROLASES; PROTEINS; RECOMBINANT FUSION PROTEINS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THIAZOLES;

EID: 84873744026     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-12-17     Document Type: Note

References (46)

1. Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 2006, 75:333-366. 10.1146/annurev.biochem.75.101304.123901, 16756495.
2. Marston FAO. The purification of eukaryotic polypeptides synthesized in escherichia-coli. Biochem J 1986, 240:1-12. 1147368, 3548705.
3. Villaverde A, Carrio MM. Protein aggregation in recombinant bacteria: biological role of inclusion bodies. Biotechnol Lett 2003, 25:1385-1395. 10.1023/A:1025024104862, 14514038.
4. Garcia-Fruitos E. Inclusion bodies: a new concept. Microb Cell Fact 2010, 9:80. 10.1186/1475-2859-9-80, 2987918, 21040537.
5. Gatti-Lafranconi P, Natalello A, Ami D, Doglia SM, Lotti M. Concepts and tools to exploit the potential of bacterial inclusion bodies in protein science and biotechnology. FEBS J 2011, 278:2408-2418. 10.1111/j.1742-4658.2011.08163.x, 21569207.
6. Patra AK, Mukhopadhyay R, Mukhija R, Krishnan A, Garg LC, Panda AK. Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli. Protein Expr Purif 2000, 18:182-192. 10.1006/prep.1999.1179, 10686149.
7. Peternel S, Grdadolnik J, Gaberc-Porekar V, Komel R. Engineering inclusion bodies for non denaturing extraction of functional proteins. Microb Cell Fact 2008, 7:34. 10.1186/1475-2859-7-34, 2630956, 19046444.
8. Peternel S, Komel R. Isolation of biologically active nanomaterial (inclusion bodies) from bacterial cells. Microb Cell Fact 2010, 9:66. 10.1186/1475-2859-9-66, 2944166, 20831775.
9. Carrio M, Gonzalez-Montalban N, Vera A, Villaverde A, Ventura S. Amyloid-like properties of bacterial inclusion bodies. J Mol Biol 2005, 347:1025-1037. 10.1016/j.jmb.2005.02.030, 15784261.
10. Sabate R, Espargaro A, Saupe SJ, Ventura S. Characterization of the amyloid bacterial inclusion bodies of the HET-s fungal prion. Microb Cell Fact 2009, 8:56. 10.1186/1475-2859-8-56, 2774669, 19863787.
11. Garcia-Fruitos E, Sabate R, de Groot NS, Villaverde A, Ventura S. Biological role of bacterial inclusion bodies: a model for amyloid aggregation. FEBS J 2011, 278:2419-2427. 10.1111/j.1742-4658.2011.08165.x, 21569209.
12. Villar-Pique A, Ventura S. Modeling amyloids in bacteria. Microb Cell Fact 2012, 11:166. 10.1186/1475-2859-11-166, 3539947, 23272903.
13. Espargaro A, Villar-Pique A, Sabate R, Ventura S. Yeast prions form infectious amyloid inclusion bodies in bacteria. Microb Cell Fact 2012, 11:89. 10.1186/1475-2859-11-89, 3520751, 22731490.
14. Villar-Pique A, Espargaro A, Sabate R, de Groot N, Ventura S. Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors. Microb Cell Fact 2012, 11:55. 10.1186/1475-2859-11-55, 3495732, 22553999.
15. Invernizzi G, Aprile FA, Natalello A, Ghisleni A, Penco A, Relini A, Doglia SM, Tortora P, Regonesi ME. The relationship between aggregation and toxicity of polyglutamine-containing ataxin-3 in the intracellular environment of escherichia coli. PLoS One 2012, 7:e51890. 10.1371/journal.pone.0051890, 3522584, 23251648.
16. Garcia-Fruitos E, Gonzalez-Montalban N, Morell M, Vera A, Ferraz R, Aris A, Ventura S, Villaverde A. Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb Cell Fact 2005, 4:27. 10.1186/1475-2859-4-27, 1224866, 16156893.
17. Garcia-Fruitos E, Seras-Franzoso J, Vazquez E, Villaverde A. Tunable geometry of bacterial inclusion bodies as substrate materials for tissue engineering. Nanotechnology 2010, 21:205101. 10.1088/0957-4484/21/20/205101, 20413834.
18. Liovic M, Ozir M, Zavec A, Peternel S, Komel R, Zupancic T. Inclusion bodies as potential vehicles for recombinant protein delivery into epithelial cells. Microb Cell Fact 2012, 11:67. 10.1186/1475-2859-11-67, 3434093, 22624805.
19. Villaverde A, Garcia-Fruitos E, Rinas U, Seras-Franzoso J, Kosoy A, Corchero JL, Vazquez E. Packaging protein drugs as bacterial inclusion bodies for therapeutic applications. Microb Cell Fact 2012, 11:76. 10.1186/1475-2859-11-76, 3538617, 22686540.
20. Gasser B, Saloheimo M, Rinas U, Dragosits M, Rodriguez-Carmona E, Baumann K, Giuliani M, Parrilli E, Branduardi P, Lang C, et al. Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overview. Microb Cell Fact 2008, 7:11. 10.1186/1475-2859-7-11, 2322954, 18394160.
21. Ignatova Z. Monitoring protein stability in vivo. Microb Cell Fact 2005, 4:23. 10.1186/1475-2859-4-23, 1208943, 16120213.
22. Garcia-Fruitos E, Aris A, Villaverde A. Localization of functional polypeptides in bacterial inclusion bodies. Appl Environ Microbiol 2007, 73:289-294. 10.1128/AEM.01952-06, 1797118, 17085715.
23. Wu W, Xing L, Zhou B, Lin Z. Active protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coli. Microb Cell Fact 2011, 10:9. 10.1186/1475-2859-10-9, 3045283, 21320350.
24. Zhou B, Xing L, Wu W, Zhang X-E, Lin Z. Small surfactant-like peptides can drive soluble proteins into active aggregates. Microb Cell Fact 2012, 11:10. 10.1186/1475-2859-11-10, 3398302, 22251949.
25. Kim W, Hecht MH. Sequence determinants of enhanced amyloidogenicity of Alzheimer A beta 42 peptide relative to A beta 40. J Biol Chem 2005, 280:35069-35076. 10.1074/jbc.M505763200, 16079141.
26. Kim W, Kim Y, Min J, Kim DJ, Chang YT, Hecht MH. A high-throughput screen for compounds that inhibit aggregation of the Alzheimer's peptide. ACS Chem Biol 2006, 1:461-469. 10.1021/cb600135w, 17168524.
27. Kim W, Hecht MH. Mutations enhance the aggregation propensity of the Alzheimer's A beta peptide. J Mol Biol 2008, 377:565-574. 10.1016/j.jmb.2007.12.079, 2346586, 18258258.
28. Zhao Y, He W, Liu WF, Liu CC, Feng LK, Sun L, Yan YB, Hang HY. Two distinct states of escherichia coli cells that overexpress recombinant heterogeneous beta-galactosidase. J Biol Chem 2012, 287:9259-9268. 10.1074/jbc.M111.327668, 22303013.
29. Morell M, Bravo R, Espargaro A, Sisquella X, Aviles FX, Fernandez-Busquets X, Ventura S. Inclusion bodies: Specificity in their aggregation process and amyloid-like structure. Biochim Biophys Acta 2008, 1783:1815-1825. 10.1016/j.bbamcr.2008.06.007, 18619498.
30. Ignatova Z, Gierasch LM. Monitoring protein stability and aggregation in vivo by real-time fluorescent labeling. Proc Natl Acad Sci USA 2004, 101:523-528. 10.1073/pnas.0304533101, 327180, 14701904.
31. Ignatova Z, Gierasch LM. A Fluorescent Window Into Protein Folding and Aggregation in Cells. Biophysical Tools for Biologists, Vol 2: In Vivo Techniques 2008, 59-70. Elsevier Academic Press Inc, San Diego, Correia JJ, Detrich HW, Methods in Cell Biology].
32. Espargaro A, Sabate R, Ventura S. Thioflavin-S staining coupled to flow cytometry. A screening tool to detect in vivo protein aggregation. Mol Biosyst 2012, 8:2839-2844. 10.1039/c2mb25214g, 22868714.
33. Ami D, Bonecchi L, Cali S, Orsini G, Tonon G, Doglia SM. FT-IR study of heterologous protein expression in recombinant Escherichia coli strains. Biochim Biophys Acta 2003, 1624:6-10. 10.1016/j.bbagen.2003.09.008, 14642807.
34. Ami D, Natalello A, Taylor G, Tonon G, Doglia SM. Structural analysis of protein inclusion bodies by Fourier transform infrared microspectroscopy. Biochim Biophys Acta 2006, 1764:793-799. 10.1016/j.bbapap.2005.12.005, 16434245.
35. Ami D, Natalello A, Gatti-Lafranconi P, Lotti M, Doglia SM. Kinetics of inclusion body formation studied in intact cells by FT-IR spectroscopy. FEBS Lett 2005, 579:3433-3436. 10.1016/j.febslet.2005.04.085, 15949804.
36. Ami D, Natalello A, Doglia SM. Fourier transform infrared microspectroscopy of complex biological systems: From intact cells to whole organisms. Intrinsically Disordered Protein Analysis: Volume 1, Methods and Experimental Tools 2012, 85-100. New York: Humana Press, Uversky VN, Dunker AK, Methods in Molecular Biology.
37. Ami D, Natalello A, Schultz T, Gatti-Lafranconi P, Lotti M, Doglia SM, de Marco A. Effects of recombinant protein misfolding and aggregation on bacterial membranes. Biochim Biophys Acta 2009, 1794:263-269. 10.1016/j.bbapap.2008.10.015, 19059501.
38. Oberg K, Chrunyk BA, Wetzel R, Fink AL. Native-like secondary structure in interleukin-1-beta inclusion-bodies by attenuated total reflectance ftir. Biochemistry 1994, 33:2628-2634. 10.1021/bi00175a035, 8117725.
39. Doglia SM, Ami D, Natalello A, Gatti-Lafranconi P, Lotti M. Fourier transform infrared spectroscopy analysis of the conformational quality of recombinant proteins within inclusion bodies. Biotechnol J 2008, 3:193-201. 10.1002/biot.200700238, 18213662.
40. Wang L, Maji SK, Sawaya MR, Eisenberg D, Riek R. Bacterial inclusion bodies contain amyloid-like structure. PLoS Biol 2008, 6:e195. 10.1371/journal.pbio.0060195, 2494559, 18684013.
41. Wasmer C, Benkemoun L, Sabate R, Steinmetz MO, Coulary-Salin B, Wang L, Riek R, Saupe SJ, Meier BH. Solid-State NMR Spectroscopy Reveals that E. coli Inclusion Bodies of HET-s(218-289) are Amyloids. Angew Chem Int Ed 2009, 48:4858-4860.
42. Wang L, Schubert D, Sawaya MR, Eisenberg D, Riek R. Multidimensional structure-activity relationship of a protein in its aggregated states. Angew Chem Int Ed 2010, 49:3904-3908.
43. Curtis-Fisk J, Spencer RM, Weliky DP. Native conformation at specific residues in recombinant inclusion body protein in whole cells determined with solid-state NMR spectroscopy. J Am Chem Soc 2008, 130:12568-12569. 10.1021/ja8039426, 18759389.
44. Lesley SA, Graziano J, Cho CY, Knuth MW, Klock HE. Gene expression response to misfolded protein as a screen for soluble recombinant protein. Protein Eng 2002, 15:153-160. 10.1093/protein/15.2.153, 11917152.
45. Schultz T, Martinez L, de Marco A. The evaluation of the factors that cause aggregation during recombinant expression in E. coli is simplified by the employment of an aggregation-sensitive reporter. Microb Cell Fact 2006, 5:28. 10.1186/1475-2859-5-28, 1564408, 16948849.
46. Kraft M, Knüpfer U, Wenderoth R, Pietschmann P, Hock B, Horn U. An online monitoring system based on a synthetic sigma32-dependent tandem promoter for visualization of insoluble proteins in the cytoplasm of Escherichia coli. Appl Microbiol Biotechnol 2007, 75:397-406. 10.1007/s00253-006-0815-6, 17221192.